RADELLA
Live / Applied — Statement of use — non-final action mailed (as of 01 Sept 2026)
Now
Refused for now — an office action was mailed 01 Sept 2026.
A response is due by 01 Dec 2026; with no response the application is abandoned.
What this means for you
Not registered yet, but its 19 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97509877
- Mark type
- Word mark
- Filed
- 19 Jul 2022
- Published for opposition
- 13 Jun 2023
- Attorney of record
- Amy J Benjamin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of diabetes, heart disease and obesity
Owner
- Cohen Global Pharmaceuticals Inc., Brooklyn, NY, US
- Cohen Global Pharmaceuticals Inc., Brooklyn, NY, US
Prosecution history
- 01 Sept 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Sept 2026 — NON-FINAL ACTION E-MAILED
- 01 Sept 2026 — SU - NON-FINAL ACTION - WRITTEN
- 19 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Aug 2026 — USE AMENDMENT FILED
- 10 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2026 — SOU EXTENSION 5 GRANTED
- 04 Feb 2026 — SOU EXTENSION 5 FILED
- 04 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Aug 2025 — SOU EXTENSION 4 GRANTED
- 07 Aug 2025 — SOU EXTENSION 4 FILED
- 07 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED